DrugJul 29, 2015
Wockhardt Usa Azithromycin Tablets, USP, 600 mg Tablets recall — FDA D-1264-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
Recall history in this database
Classification mix: Class II: 37, Class III: 1.
DrugJul 29, 2015
Wockhardt Usa Lisinopril Tablets USP, 5 mg Tablets,Packaged in A) 100 Count Bottles recall — FDA D-1257-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules recall — FDA D-1268-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Zolpidem Tartrate Tablets, 5 mg Tablets, CIV recall — FDA D-1247-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Captopril Tablets, USP, 100 mg Tablets recall — FDA D-1277-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Lansoprazole Delayed-Release Capsules, USP, 30 mg Capsules recall — FDA D-1269-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Zonisamide Capsules, 25 mg Capsules recall — FDA D-1274-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Amlodipine Besylate Tablets, 5 mg Tablets, Packaged as A) 90 Count Bottles recall — FDA D-1255-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Zonisamide Capsules, 100 mg Capsules recall — FDA D-1254-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Captopril Tablets, USP, 50 mg Tablets recall — FDA D-1276-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Metoprolol Succinate Extended-Release Tablets, USP, 100 mg Tablets recall — FDA D-1270-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Lisinopril Tablets USP, 30 mg Tablets recall — FDA D-1260-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Famotodine Tablets, USP, 10 mg Tablets, For Repacking Only recall — FDA D-1267-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
DrugJul 29, 2015
Wockhardt Usa Lisinopril Tablets USP, 10 mg Tablets recall — FDA D-1258-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class IIFDA: TerminatedWockhardt Usa Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Wockhardt Usa Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.